Stocks to watch
Upgrades, downgrades, or major signals – these stocks are making waves.
The stock screener that catches what looks good but isn't.
Compare Health, Risk, Performance, and Trend on every stock, side by side.
Overall stock screener, find the best stocks at a glance. Rankings combine Stoxcraft Rating, Health, Performance, Risk, Trend and BuyMeter, so you see what matters first. Filter by sector, market cap or dividend, and check the Earnings Streak to spot stocks that consistently beat expectations.
| Symbol | Name | Rating | Price | Today | Health | Performance | Risk | Trend | BuyMeter | ESG Score | Earning Streak | Market Cap | Volume | P/E | Dividend | Sector | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
BSVN
|
Bank7 Corp. | 51.68 USD | -0.62 % | 3.0 | Buy | 68.14 | 481.39M | 24,056 | 9 | 2.37 % | Financial Services | Banks - Regional | |||||
|
EHC
|
Encompass Health Corporation | 125.83 USD | +0.80 % | 3.2 | Buy | 91.16 | 12.42B | 968,959 | 19 | 0.62 % | Healthcare | Medical - Care Facilities | |||||
|
DGX
|
Quest Diagnostics Incorporated | 239.01 USD | +0.47 % | 2.9 | Buy | 62.90 | 26.31B | 933,366 | 20 | 1.59 % | Healthcare | Medical - Diagnostics & Research | |||||
|
JNJ
|
Johnson & Johnson | 261.26 USD | +0.15 % | 1.7 | Buy | 74.50 | 624.74B | 8.28M | 19 | 2.04 % | Healthcare | Drug Manufacturers - General | |||||
|
MCK
|
McKesson Corporation | 867.90 USD | -1.23 % | 2.8 | Hold | 60.63 | 101.81B | 1.15M | 22 | 0.39 % | Healthcare | Medical - Distribution | |||||
|
NVS
|
Novartis AG | 152.40 USD | +0.05 % | 1.8 | Buy | 73.36 | 297.14B | 1.84M | 18 | - | Healthcare | Drug Manufacturers - General | |||||
|
RPRX
|
Royalty Pharma plc | 59.18 USD | -0.07 % | 2.0 | Buy | 62.14 | 25.16B | 3.58M | 17 | 1.63 % | Healthcare | Medical - Pharmaceuticals | |||||
|
SAN
|
Banco Santander, S.A. | 14.99 USD | +1.11 % | 3.3 | Hold | 74.18 | 215.77B | 9.59M | 11 | - | Financial Services | Banks - Diversified | |||||
|
TEVA
|
Teva Pharmaceutical Industries Limited | 36.96 USD | +0.60 % | 2.4 | Hold | 60.66 | 41.18B | 5.73M | 26 | - | Healthcare | Drug Manufacturers - Specialty & Generic | |||||
|
HQY
|
HealthEquity, Inc. | 106.29 USD | +0.74 % | 3.4 | Buy | 71.99 | 8.75B | 935,712 | 34 | - | Healthcare | Medical - Healthcare Information Services | |||||
|
CORT
|
Corcept Therapeutics Incorporated | 111.60 USD | -0.52 % | 6.9 | Buy | 52.07 | 11.97B | 1.17M | 37 | - | Healthcare | Medical - Pharmaceuticals | |||||
|
CPRX
|
Catalyst Pharmaceuticals, Inc. | 31.49 USD | 0.00 % | 4.9 | Strong Buy | 66.83 | 3.85B | 3.01M | 13 | - | Healthcare | Biotechnology | |||||
|
LNTH
|
Lantheus Holdings, Inc. | 100.87 USD | +0.13 % | 5.3 | Strong Buy | 69.32 | 6.57B | 1.25M | 19 | - | Healthcare | Drug Manufacturers - Specialty & Generic | |||||
|
PR
|
Permian Resources Corporation | 21.25 USD | -0.93 % | 2.2 | Buy | 60.25 | 16.87B | 10.08M | 11 | 3.32 % | Energy | Oil & Gas Exploration & Production | |||||
|
TS
|
Tenaris S.A. | 52.82 USD | -0.62 % | 3.3 | Buy | 66.42 | 28.46B | 1.31M | 10 | - | Energy | Oil & Gas Equipment & Services | |||||
|
WES
|
Western Midstream Partners, LP | 48.50 USD | +0.69 % | 1.9 | Buy | 69.42 | 19.26B | 1.06M | 13 | 7.90 % | Energy | Oil & Gas Midstream | |||||
|
NRP
|
Natural Resource Partners L.P. | 103.56 USD | +0.55 % | 3.6 | Strong Buy | 69.34 | 1.42B | 53,898 | 10 | 2.92 % | Energy | Coal | |||||
|
INVX
|
Innovex International, Inc. | 30.22 USD | -0.56 % | 4.0 | Buy | 59.87 | 1.96B | 492,298 | 18 | - | Energy | Oil & Gas Equipment & Services | |||||
|
NESR
|
National Energy Services Reunited Corp. | 34.87 USD | +0.14 % | 3.5 | Buy | 61.07 | 2.93B | 2.12M | 30 | - | Energy | Oil & Gas Equipment & Services | |||||
|
PARR
|
Par Pacific Holdings, Inc. | 79.49 USD | +2.20 % | 6.8 | Strong Buy | 68.90 | 3.32B | 1.03M | 5 | - | Energy | Oil & Gas Refining & Marketing | |||||
|
ABBV
|
AbbVie Inc. | 253.08 USD | +1.74 % | 2.9 | Hold | 64.62 | 434.70B | 6.82M | 96 | 2.80 % | Healthcare | Drug Manufacturers - General | |||||
|
MRK
|
Merck & Co., Inc. | 133.49 USD | +0.43 % | 1.7 | Buy | 73.88 | 317.54B | 10.23M | 14 | 2.64 % | Healthcare | Drug Manufacturers - General | |||||
|
AMGN
|
Amgen Inc. | 418.23 USD | +0.49 % | 1.7 | Buy | 58.77 | 221.79B | 2.73M | 23 | 2.42 % | Healthcare | Drug Manufacturers - General | |||||
|
GILD
|
Gilead Sciences, Inc. | 136.51 USD | +0.47 % | 2.3 | Hold | 58.65 | 165.39B | 7.73M | 18 | 2.44 % | Healthcare | Drug Manufacturers - General | |||||
|
REGN
|
Regeneron Pharmaceuticals, Inc. | 798.02 USD | 0.00 % | 3.0 | Buy | 49.91 | 80.81B | 1.02M | 18 | 0.47 % | Healthcare | Biotechnology | |||||
|
CAH
|
Cardinal Health, Inc. | 233.22 USD | -0.40 % | 3.8 | Hold | 58.95 | 55.37B | 2.33M | 26 | 0.86 % | Healthcare | Medical - Distribution | |||||
|
THC
|
Tenet Healthcare Corporation | 268.01 USD | +0.46 % | 4.2 | Strong Buy | 73.70 | 21.11B | 1.39M | 13 | - | Healthcare | Medical - Care Facilities | |||||
|
FBP
|
First BanCorp. | 29.40 USD | +0.65 % | 3.4 | Strong Buy | 61.16 | 4.38B | 1.54M | 10 | 2.72 % | Financial Services | Banks - Regional | |||||
|
IFS
|
Intercorp Financial Services Inc. | 55.09 USD | +0.40 % | 5.4 | Hold | 70.55 | 6.55B | 305,280 | 9 | - | Financial Services | Banks - Regional | |||||
|
IX
|
ORIX Corporation | 40.42 USD | -0.39 % | 3.4 | Buy | 67.77 | 44.51B | 277,498 | 12 | - | Financial Services | Financial - Credit Services |
The stock screener that compares every stock to the right benchmark
Stoxcraft is a free stock screener, and it doesn't just dump numbers on you. On the Health tab, every fundamental metric is color coded against its sector average, so you see instantly whether a number is actually good, or just average dressed up as good. The Risk tab flips the comparison to the overall market instead of a sector. A calm balance sheet is a calm balance sheet, whether you're in Tech or Utilities.
No finance degree required. Dividend hunters can turn on Dividends Only and use this as a dedicated dividend stock screener, built to separate real payout safety from a headline yield. Day traders get the Trend tab instead, RSI and volume doing the real talking before a move even shows up in the price. And for anyone screening with a longer horizon, this doubles as a growth stock screener too: Revenue Growth 5Y sits right next to Income Growth 5Y, so you can tell a real compounder from one good quarter. Pick a tab, and know within seconds whether a stock deserves a second look.